19-55047392-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001145971.2(RDH13):c.755C>T(p.Thr252Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,611,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in Lovd as Likely benign (no stars).
Frequency
Consequence
NM_001145971.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RDH13 | NM_001145971.2 | c.755C>T | p.Thr252Ile | missense_variant | 6/7 | ENST00000415061.8 | NP_001139443.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RDH13 | ENST00000415061.8 | c.755C>T | p.Thr252Ile | missense_variant | 6/7 | 1 | NM_001145971.2 | ENSP00000391121.2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000368 AC: 9AN: 244414Hom.: 0 AF XY: 0.0000301 AC XY: 4AN XY: 133074
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1459456Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 32AN XY: 725926
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2024 | The c.755C>T (p.T252I) alteration is located in exon 6 (coding exon 6) of the RDH13 gene. This alteration results from a C to T substitution at nucleotide position 755, causing the threonine (T) at amino acid position 252 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at